A study analyzing side effects during the week after first dose vaccination with four Covid-19 vaccines- ProVaVac Survey
Latest Information Update: 09 Sep 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms ProVaVac
Most Recent Events
- 09 Sep 2022 New trial record
- 29 Aug 2022 Results published in the Vaccine